AI Verdict
RPAY has stronger fundamentals based on our AI analysis.
RPID vs RPAY Fundamental Comparison
| Metric | RPID | RPAY |
|---|---|---|
| Revenue | $33.6M | $309.3M |
| Net Income | $-47.1M | $-256.7M |
| Net Margin | -140.3% | -83.0% |
| ROE | -141.9% | -53.0% |
| ROA | -63.0% | -21.4% |
| Current Ratio | 3.31x | 0.82x |
| Debt/Equity | 0.57x | 0.58x |
| EPS | $-1.05 | $-3.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RPID vs RPAY: Frequently Asked Questions
Is RPID or RPAY a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RPAY has stronger fundamentals. RPID is rated SELL (75% confidence) while RPAY is rated SELL (77% confidence). This is not investment advice.
How does RPID compare to RPAY fundamentally?
RAPID MICRO BIOSYSTEMS, INC. has ROE of -141.9% vs Repay Holdings Corp's -53.0%. Net margins are -140.3% vs -83.0% respectively.
Which stock pays higher dividends, RPID or RPAY?
RPID has a dividend yield of N/A or no dividend while RPAY has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RPID or RPAY for long term?
For long-term investing, consider that RPID has SELL rating with 75% confidence, while RPAY has SELL rating with 77% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RPID vs RPAY?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RPID vs RPAY, the AI consensus favors RPAY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.